Clinical Trial Update: CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL [Phase 1]

View source ↗

Summary

Phase 1 study evaluating CD19 CAR-T cells in B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; the trial is active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma
• Chronic Lymphocytic Leukemia

Drugs mentioned

• CD19 CAR T cells

Snippet

Sponsor: Baylor College of Medicine | Conditions: B Cell Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Status: ACTIVE_NOT_RECRUITING